[PDF] Top 20 Las Artes Plasticas en Venezuela en El Siglo Xix
Has 10000 "Las Artes Plasticas en Venezuela en El Siglo Xix" found on our website. Below are the top 20 most common "Las Artes Plasticas en Venezuela en El Siglo Xix".
Glial activation and inflammation along the Alzheimer’s disease continuum
... Alzheimer’s disease (AD) may be described as a bio- logical continuum that includes the hallmark patho- logical processes of amyloid-beta (Aβ) dysmetabolism, formation of amyloid deposits (A), ... See full document
7
Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study
... elevated glial metabolic rate in patients with MCI and AD in proportion to the elevation in glial marker myoinositol of conventional proton MRS, and inversely correlated with a clinical measure of cognitive ... See full document
18
The 21st century epidemic: infections as inductors of neuro-degeneration associated with Alzheimer’s Disease
... ’ s disease (AD) is a complex disease resulting in neurodegeneration and cognitive ...the disease remains up to now obscure. The disease ’ s pathogenesis may be multi-factorial ... See full document
182
Rodent models of neuroinflammation for Alzheimer’s disease
... neuro- inflammation is mainly known as a secondary response to sustained Aβ overproduction and ...microglial activation and variable involvement of the complement system and production of cytokines ...early ... See full document
24
Evidence of the impact of systemic inflammation on neuroinflammation from a non-bacterial endotoxin animal model
... Beyond its classical role in stabilizing microtubule, tau has other cellular functions such as regulating microtu- bules assembly, dynamic behavior, and the axonal trans- port under physiological conditions via ... See full document
7
Activation of microglia induces symptoms of Parkinson’s disease in wild-type, but not in IL-1 knockout mice
... mouse glial fibrillary acidic protein (GFAP) antibody from Sigma-Aldrich (St Louis, MO), monoclonal goat anti- mouse CD11b antibody from Serotec Ltd (Oxford, UK), goat anti-murine IL-1β antibody from R&D ... See full document
163
For debate: substituting placebo controls in long-term Alzheimer's prevention trials
... If supported by further evidence, where in the clinical development process of a new compound aimed at sec- ondary prevention of dementia due to AD could be the place for the proposed PGSA? No doubt some of the earlier ... See full document
58
Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
... for disease intervention in AD, as Aβ immunotherapy in general confers a lower risk of side effects in a vulner- able patient population during long-term treatment as compared with small-molecule anti-Aβ ... See full document
88
SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment
... Sample size calculation is based on changes in our primary outcome: global cognitive function measured using the Alzheimer Disease Assessment Scale Cognitive 13 and the plus modality (ADAS-Cog 13 and plus). ... See full document
16
The genetics of Alzheimer's disease
... Alzheimer’s disease (AD) is a complex and heterogeneous neurodegenerative disorder, classified as either early onset (under 65 years of age), or late onset (over 65 years of ... See full document
13
Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?
... Alzheimer’s disease (AD) are two of the most com- mon dementia syndromes affecting people under the age of 65 ...for disease management and treatment ...the disease [6, ...early disease stages ... See full document
17
Imago Mundi, Imago AD, Imago ADNI
... likely to emerge within the next decade aimed at prevent- ing or delaying the onset of symptoms. Data gathered from different ADNI sites concurred in showing that some of the pathological changes characteristic of the ... See full document
106
The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group
... following disease-specific tools that show a good validity level is recommended: UPDRS; Unified Huntington’s Disease Rating Scale (UHDRS); Progressive Supranuclear Palsy Rating Scale (PSPRS); Unified ... See full document
167
Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
... the disease, not the Aβ accumulation that (unlike in FAD) may, or may not, occur during the course of the ...the disease in this open-ended, systemic fashion will allow clinicians and scientists to identify ... See full document
5
Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel
... Microscopically, there is severe spongiosus of layer 2 of the cerebral cortex and widespread neuronal loss. Neurons in the substantia nigra are severely depleted. There is prominent, patchy, widespread myelin loss and ... See full document
131
Neuroinflammation in Alzheimer’s disease
... A β plaques are frequently associated with the activation of microglia and astrocytes (see the section “Cell mediators”). A β induces the expression of inflammatory cytokines and inflammatory enzymes such as COX-2 ... See full document
17
ALZHEIMER’S DISEASE: A REVIEW
... of glial cells, astrocytes and microglia, are also found in ...functions, glial cells secrete inflammatory mediators and serve as scavenger cells, which may be important in causing the inflammatory ... See full document
121
Cognitive reserve and clinical progression in Alzheimer diseaseA paradoxical relationship
... In the present study we investigated how CR, defined as the degree to which an individual’s observed cerebral damage was higher or lower than predicted from cognitive performance, affected clinical progression in AD. In an ... See full document
7
Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels
... between disease (AD risk) and either ...Alzheimer’s Disease Genetic Consor- tium (ADGC) and secondarily with results from the International Genomics of Alzheimer’ s Project (IGAP) con- sortium ... See full document
121
Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies
... JP and MS are employees of Boehringer Ingelheim Pharma GmbH & Co. KG. TK undertakes work for Boehringer Ingelheim Pharma GmbH & Co. KG as an external contractor. JH has previously received honoraria and ... See full document
55
Related subjects